p53 tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx

Cancer

Volumn 73, Issue 1, 1994, Pages 181-186

  Frank, James L ^a   Bur, Martin E ^a   Garb, Jane L ^a   Kay, Saul ^b   Ware, Joy L ^b   Sismanis, Aristides ^b   Neifeld, James P ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

head and neck cancer; multivariate analysis; p53; prognostic factors

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CELL CYCLE S PHASE; CLINICAL ARTICLE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; IMMUNOHISTOCHEMISTRY; MULTIPLE CANCER; MULTIVARIATE ANALYSIS; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

AGE FACTORS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENES, P53; HUMAN; HYPOPHARYNGEAL NEOPLASMS; MIDDLE AGE; NEOPLASM STAGING; PLOIDIES; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; S PHASE; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL RATE;

EID: 0028177863     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19940101)73:1<181::AID-CNCR2820730131>3.0.CO;2-3     Document Type: Article

References (34)

1. Participation of p53 protein in the cellular response to DNA damage
2. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer
3. Absence of p53 gene mutations in primary nasopharyngeal carcinomas
4. Amplification of a gene encoding a p53‐associated protein in human sarcomas
5. Abnormal expression of wild‐type p53 in normal cells of a cancer family patient
6. p53 mutations in colorectal cancer
7. Formal hepatic resection of colorectal liver metastases
8. Nonparametric estimation from incomplete observations
9. Evaluation of survival data and two new rank order statistics arising in its consideration
10. Regression models and life tables
11. Planning the size and duration of a clinical trial studying the time to some critical event
12. Cooperation between gene encoding p53 tumor antigen and ras in cellular transformation
13. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation
14. High incidence of lung, bone and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene
15. p53 mutations in human cancers
16. p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor, c‐erbB‐2 protein overexpression, and estrogen receptor
17. Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas
18. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas
19. Genetic alterations during colorectal‐tumor development
20. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers
21. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer
22. p53 expression in breast cancer
23. Frequent p53 mutations in head and neck cancer
24. p53 overexpression correlates with increased survival in patients with squamous carcinoma of the tongue base
25. Prognostic significance of p53 overexpression in gastric and colorectal carcinoma
26. Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node‐negative breast cancer patients
27. p53, guardian of the genome
28. Suppression of human colorectal carcinoma cell growth by wild‐type p53
29. p53 gene mutations in human gastric cancer: wild‐type but not mutant p53 suppresses growth of human gastric cancer cells